Bipartisan Bill Fights Drug Monopolies for Patients
Submitted by MAGA
Posted 2 hours ago
The Patients Before Monopolies Act is sparking considerable conversation in the Capitol, as a bipartisan coalition of lawmakers, including Republican Senator Josh Hawley of Missouri, takes aim at the pharmaceutical industry’s entrenched practices that many believe have inflated drug prices and stifled competition.
Under current operations, pharmacy-benefit managers (PBMs) wield substantial power within the healthcare system but have come under scrutiny for their practices that critics argue have manipulated drug prices to their advantage. This legislation seeks to address those issues directly by banning the joint ownership of PBMs and pharmacies.
Senator Hawley stated, “Insurance monopolies are ruining American health care. Patients and independent pharmacies are paying the price. This legislation will stop the insurance companies and PBMs from gobbling up even more of American health care and charging American families more and more for less.”
This bill, supported by a diverse array of groups, including the National Community Pharmacists Association and Patients Rising, aims to untangle the conflicts of interest that exist when a pharmacy is owned by a parent company that also manages a PBM. By doing so, proponents believe it will promote transparency and reduce costs for consumers.
The consequences of allowing these monopolies to persist are evident, as independent pharmacies struggle to survive in an increasingly hostile environment. Small business owners are reporting difficulties competing against larger entities that can leverage their economies of scale. This has led to a concerning trend where independent pharmacies are being pushed out of business, further limiting patient access to quality care.
Supporters of the Patients Before Monopolies Act see this as a pivotal moment to reform the healthcare sector. By separating these interests, the legislation aims to ensure that patients take precedence over profits in a healthcare system that has been criticized for its lack of accountability.
As discussions continue in Congress, many are hopeful that this bipartisan effort can finally lead to meaningful changes that benefit ordinary Americans who have long been burdened by rising healthcare costs. The path may be difficult, but initiatives like the Patients Before Monopolies Act highlight a growing willingness among some lawmakers to stand up against monopolistic practices in favor of patients and independent providers alike.
Sources:
gatewayhispanic.com
americanactionnews.com
trialsitenews.com
Under current operations, pharmacy-benefit managers (PBMs) wield substantial power within the healthcare system but have come under scrutiny for their practices that critics argue have manipulated drug prices to their advantage. This legislation seeks to address those issues directly by banning the joint ownership of PBMs and pharmacies.
Senator Hawley stated, “Insurance monopolies are ruining American health care. Patients and independent pharmacies are paying the price. This legislation will stop the insurance companies and PBMs from gobbling up even more of American health care and charging American families more and more for less.”
This bill, supported by a diverse array of groups, including the National Community Pharmacists Association and Patients Rising, aims to untangle the conflicts of interest that exist when a pharmacy is owned by a parent company that also manages a PBM. By doing so, proponents believe it will promote transparency and reduce costs for consumers.
The consequences of allowing these monopolies to persist are evident, as independent pharmacies struggle to survive in an increasingly hostile environment. Small business owners are reporting difficulties competing against larger entities that can leverage their economies of scale. This has led to a concerning trend where independent pharmacies are being pushed out of business, further limiting patient access to quality care.
Supporters of the Patients Before Monopolies Act see this as a pivotal moment to reform the healthcare sector. By separating these interests, the legislation aims to ensure that patients take precedence over profits in a healthcare system that has been criticized for its lack of accountability.
As discussions continue in Congress, many are hopeful that this bipartisan effort can finally lead to meaningful changes that benefit ordinary Americans who have long been burdened by rising healthcare costs. The path may be difficult, but initiatives like the Patients Before Monopolies Act highlight a growing willingness among some lawmakers to stand up against monopolistic practices in favor of patients and independent providers alike.
Sources:
gatewayhispanic.com
americanactionnews.com
trialsitenews.com
Latest News